Lucile Warter Selected Research

Glycoproteins (Glycoprotein)

9/2023	Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models.
12/2012	Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucile Warter Research Topics

Disease

5	Infections 01/2019 - 12/2011
4	Dengue (Dengue Fever) 01/2019 - 12/2012
3	Viremia 01/2019 - 12/2015
2	Malaria 08/2023 - 09/2011
1	Respiratory Syncytial Virus Infections 09/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Severe Dengue 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 12/2015
1	Chikungunya Fever 01/2013
1	Virus Diseases (Viral Diseases) 09/2012
1	Persistent Infection 12/2011
1	Hepatitis C 01/2009

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 09/2023 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2009
3	Neutralizing AntibodiesIBA 01/2019 - 09/2012
2	adjuvant system 01IBA 09/2023 - 01/2023
2	Glycoproteins (Glycoprotein)IBA 09/2023 - 12/2012
2	Inactivated VaccinesIBA 01/2019 - 04/2015
2	Monoclonal AntibodiesIBA 01/2013 - 12/2011
1	Interleukin-12 (IL 12)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Dengue VaccinesIBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	Blocking AntibodiesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	CytokinesIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Viral ProteinsIBA 12/2012
1	AntibodiesIBA 09/2012
1	Broadly Neutralizing AntibodiesIBA 09/2012
1	Immunoglobulin M (IgM)IBA 12/2011
1	Untranslated RNA (Noncoding RNA)IBA 01/2009

Therapy/Procedure

1	Therapeutics 12/2011